Follow RSS for latest reports on this topicRecombinant DNA - Market Research and Reports

Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology.

The procedure is to cut the DNA of the donor organism into pieces with restriction enzymes, and insert one of these fragments into the DNA of the host. Most of the time a bacterial or virus plasmid is used to insert the donor DNA. A plasmid is a circular DNA fragment, which can be opened with the same restriction enzymes as the DNA fragment of the donor. A plasmid containing DNA from the donor is called a vector. The recombinant vector can then be used to transform bacterial or virus cells. These bacterial cells are plated and colonies are grown.

Key development stages:

  • cutting and pasting pieces of DNA from different genomes using enzymes.
  • techniques used to transfer foreign DNA into new host cells
  • identification of promoters to express foreign DNA

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

REPORT HIGHLIGHTThe “Global Biosimilars Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 11.69 billion in 2019 and is anticipated to grow with 26.9% of growth rate during the future period. This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which a...Read More >>>


Published by: AnalystView

Prices Starting From:

save $488 today

Additional Searches

You may also like to search separately for: Recombinant DNA

We Stock...